Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Russell

Showing results (1311-1320 of 1,332) with videos related to

Pageof 134
Sort By:
Nature Medicine|June 19, 2019
Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trialLeonie Voorwerk, Maarten Slagter, Hugo M Horlings, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 2015
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†S Gourgou-Bourgade, D Cameron, P Poortmans, et al.
Proceedings. Biological Sciences|November 23, 2018
The role of citizen science in addressing grand challenges in food and agriculture researchS F Ryan, N L Adamson, A Aktipis, et al.
Nature Genetics|November 2, 2010
A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3)Victor Enciso-Mora, Peter Broderick, Yussanne Ma, et al.
Journal of the American Academy of Dermatology|September 8, 2024
A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6Brett G M Hughes, Alexander Guminski, Samantha Bowyer, et al.
Archives of Neurology|July 21, 2004
Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trialRobert G Holloway, Ira Shoulson, Stanley Fahn, et al.
JAMA Neurology|December 25, 2013
Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial, Michael A Schwarzschild, Alberto Ascherio, et al.
Plos Medicine|July 25, 2018
Neurodevelopmental disorders in children aged 2-9 years: Population-based burden estimates across five regions in IndiaNarendra K Arora, M K C Nair, Sheffali Gulati, et al.
Nature|January 29, 2025
An evaporite sequence from ancient brine recorded in Bennu samplesT J McCoy, S S Russell, T J Zega, et al.
Nature Geoscience|September 15, 2025
Mineralogical evidence for hydrothermal alteration of Bennu samplesT J Zega, T J McCoy, S S Russell, et al.
Pageof 134

Showing results (1311-1320 of 1,332) with videos related to

Sort By:
Pageof 134
Nature Medicine|June 19, 2019
Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trialLeonie Voorwerk, Maarten Slagter, Hugo M Horlings, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 2015
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†S Gourgou-Bourgade, D Cameron, P Poortmans, et al.
Proceedings. Biological Sciences|November 23, 2018
The role of citizen science in addressing grand challenges in food and agriculture researchS F Ryan, N L Adamson, A Aktipis, et al.
Nature Genetics|November 2, 2010
A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3)Victor Enciso-Mora, Peter Broderick, Yussanne Ma, et al.
Journal of the American Academy of Dermatology|September 8, 2024
A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6Brett G M Hughes, Alexander Guminski, Samantha Bowyer, et al.
Archives of Neurology|July 21, 2004
Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trialRobert G Holloway, Ira Shoulson, Stanley Fahn, et al.
JAMA Neurology|December 25, 2013
Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial, Michael A Schwarzschild, Alberto Ascherio, et al.
Plos Medicine|July 25, 2018
Neurodevelopmental disorders in children aged 2-9 years: Population-based burden estimates across five regions in IndiaNarendra K Arora, M K C Nair, Sheffali Gulati, et al.
Nature|January 29, 2025
An evaporite sequence from ancient brine recorded in Bennu samplesT J McCoy, S S Russell, T J Zega, et al.
Nature Geoscience|September 15, 2025
Mineralogical evidence for hydrothermal alteration of Bennu samplesT J Zega, T J McCoy, S S Russell, et al.
Pageof 134